Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMSC in Idiopathic Pulmonary Hemosiderosis
NCT02985346Phase 1Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
01
Overview
Phase 1 trial of bone marrow mesenchymal stem cells in Idiopathic Pulmonary Hemosiderosis (IPH) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Complete remission. Status: unknown.
02
Drugs
bone marrow mesenchymal stem cells
03
Conditions
Idiopathic Pulmonary Hemosiderosis (IPH)
Beyond the preview
Go deeper on NCT02985346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985346.